193 related articles for article (PubMed ID: 38380720)
1. NEAT1 repression by MED12 creates chemosensitivity in p53 wild-type breast cancer cells.
Zhang S; Kim EJ; Huang J; Liu P; Donahue K; Wang Q; Wang Y; Mcilwain S; Xie L; Chen X; Li L; Xu W
FEBS J; 2024 May; 291(9):1909-1924. PubMed ID: 38380720
[TBL] [Abstract][Full Text] [Related]
2. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
[TBL] [Abstract][Full Text] [Related]
3. JMJD6 Licenses ERα-Dependent Enhancer and Coding Gene Activation by Modulating the Recruitment of the CARM1/MED12 Co-activator Complex.
Gao WW; Xiao RQ; Zhang WJ; Hu YR; Peng BL; Li WJ; He YH; Shen HF; Ding JC; Huang QX; Ye TY; Li Y; Liu ZY; Ding R; Rosenfeld MG; Liu W
Mol Cell; 2018 Apr; 70(2):340-357.e8. PubMed ID: 29628309
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol modulates epigenetic regulators of promoter histone methylation and acetylation that restores BRCA1, p53, p21
Chatterjee B; Ghosh K; Kanade SR
Biofactors; 2019 Sep; 45(5):818-829. PubMed ID: 31317586
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA NEAT1 confers oncogenic role in triple-negative breast cancer through modulating chemoresistance and cancer stemness.
Shin VY; Chen J; Cheuk IW; Siu MT; Ho CW; Wang X; Jin H; Kwong A
Cell Death Dis; 2019 Mar; 10(4):270. PubMed ID: 30894512
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular Carcinoma and Nuclear Paraspeckles: Induction in Chemoresistance and Prediction for Poor Survival.
Kessler SM; Hosseini K; Hussein UK; Kim KM; List M; Schultheiß CS; Schulz MH; Laggai S; Jang KY; Kiemer AK
Cell Physiol Biochem; 2019; 52(4):787-801. PubMed ID: 30946555
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA NEAT1 is a transcriptional target of p53 and modulates p53-induced transactivation and tumor-suppressor function.
Idogawa M; Ohashi T; Sasaki Y; Nakase H; Tokino T
Int J Cancer; 2017 Jun; 140(12):2785-2791. PubMed ID: 28295289
[TBL] [Abstract][Full Text] [Related]
8. LncRNA NEAT1 knockdown attenuates autophagy to elevate 5-FU sensitivity in colorectal cancer via targeting miR-34a.
Liu F; Ai FY; Zhang DC; Tian L; Yang ZY; Liu SJ
Cancer Med; 2020 Feb; 9(3):1079-1091. PubMed ID: 31802650
[TBL] [Abstract][Full Text] [Related]
9. lncRNA NEAT1 promotes the Taxol resistance of breast cancer via sponging the miR-23a-3p-FOXA1 axis.
Zhu L; Wang F; Fan W; Jin Z; Teng C; Zhang J
Acta Biochim Biophys Sin (Shanghai); 2021 Aug; 53(9):1198-1206. PubMed ID: 34327529
[TBL] [Abstract][Full Text] [Related]
10. Lysine demethylase KDM3A regulates breast cancer cell invasion and apoptosis by targeting histone and the non-histone protein p53.
Ramadoss S; Guo G; Wang CY
Oncogene; 2017 Jan; 36(1):47-59. PubMed ID: 27270439
[TBL] [Abstract][Full Text] [Related]
11. p53 induces formation of NEAT1 lncRNA-containing paraspeckles that modulate replication stress response and chemosensitivity.
Adriaens C; Standaert L; Barra J; Latil M; Verfaillie A; Kalev P; Boeckx B; Wijnhoven PW; Radaelli E; Vermi W; Leucci E; Lapouge G; Beck B; van den Oord J; Nakagawa S; Hirose T; Sablina AA; Lambrechts D; Aerts S; Blanpain C; Marine JC
Nat Med; 2016 Aug; 22(8):861-8. PubMed ID: 27376578
[TBL] [Abstract][Full Text] [Related]
12. MED12 is overexpressed in glioblastoma patients and serves as an oncogene by targeting the VDR/BCL6/p53 axis.
Srivastava S; Makala H; Sharma V; Suri V; Sarkar C; Kulshreshtha R
Cell Mol Life Sci; 2022 Jan; 79(2):104. PubMed ID: 35091793
[TBL] [Abstract][Full Text] [Related]
13. The cisplatin-induced lncRNA PANDAR dictates the chemoresistance of ovarian cancer via regulating SFRS2-mediated p53 phosphorylation.
Wang H; Fang L; Jiang J; Kuang Y; Wang B; Shang X; Han P; Li Y; Liu M; Zhang Z; Li P
Cell Death Dis; 2018 Oct; 9(11):1103. PubMed ID: 30375398
[TBL] [Abstract][Full Text] [Related]
14. Expression and functions of long non-coding RNA NEAT1 and isoforms in breast cancer.
Knutsen E; Harris AL; Perander M
Br J Cancer; 2022 Mar; 126(4):551-561. PubMed ID: 34671127
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA LINP1 acts as an oncogene and promotes chemoresistance in breast cancer.
Liang Y; Li Y; Song X; Zhang N; Sang Y; Zhang H; Liu Y; Chen B; Zhao W; Wang L; Guo R; Yu Z; Yang Q
Cancer Biol Ther; 2018 Feb; 19(2):120-131. PubMed ID: 29293402
[TBL] [Abstract][Full Text] [Related]
16. The emerging role of mediator complex subunit 12 in tumorigenesis and response to chemotherapeutics.
Zhang S; O'Regan R; Xu W
Cancer; 2020 Mar; 126(5):939-948. PubMed ID: 31869450
[TBL] [Abstract][Full Text] [Related]
17. Ezh2 competes with p53 to license lncRNA Neat1 transcription for inflammasome activation.
Yuan J; Zhu Q; Zhang X; Wen Z; Zhang G; Li N; Pei Y; Wang Y; Pei S; Xu J; Jia P; Peng C; Lu W; Qin J; Cao Q; Xiao Y
Cell Death Differ; 2022 Oct; 29(10):2009-2023. PubMed ID: 35568718
[TBL] [Abstract][Full Text] [Related]
18. Long Non-coding RNA NEAT1 as an Emerging Biomarker in Breast and Gynecologic Cancers: a Systematic Overview.
Thankachan S; Bhardwaj BK; Venkatesh T; Suresh PS
Reprod Sci; 2021 Sep; 28(9):2436-2447. PubMed ID: 33569749
[TBL] [Abstract][Full Text] [Related]
19. Exosomal lncRNA NEAT1 induces paclitaxel resistance in breast cancer cells and promotes cell migration by targeting miR-133b.
Wei X; Tao S; Mao H; Zhu H; Mao L; Pei W; Shi X; Shi Y; Zhang S; Wu Y; Wei K; Wang J; Pang S; Wang W; Chen C; Yang Q
Gene; 2023 Apr; 860():147230. PubMed ID: 36717039
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase 4 mediates SMAD family member 4 deacetylation and induces 5-fluorouracil resistance in breast cancer cells.
Yu SL; Lee DC; Son JW; Park CG; Lee HY; Kang J
Oncol Rep; 2013 Sep; 30(3):1293-300. PubMed ID: 23817620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
